Return of Results

Return to Projects Page.

The purpose of defining returnable results is to define a set of genetic variants that are believed to be useful in clinical practice for purposes, such as assessment of genetic risk for complex disorders or the selection and dosing of drugs. Currently, the eMERGE Network has identified an initial set of variants that focus on common diseases and pharmacogenomics variants. The level of evidence supporting each variant along with the cost and benefit of incorporating them into patient care will be considered. Other areas of interest include genetic risk scores and susceptibility variants.

Return of results-related publications


In the News

Here's what's happening with eMerge:


The NIH/NHGRI has published IGNITE II RFAs which are linked below for your convenience.

  • Implementing Genomics in Practice (IGNITE) II: Pragmatic Clinical Trials – Clinical Groups...


CMS announced last week it will award up to $30 million in grant funding to clinical specialty societies, clinical professional organizations and independent research organizations to develop quality measures...


eMERGE is excited to share the results of the national multi-site survey it conducted to investigate public attitudes towards consent and data sharing in biobank research recently publish in AJHG.  For...


To All eRecordCounter Users, We have an upcoming scheduled maintenance window beginning Tuesday, February 21st through Sunday, February 26th. During this time, the eMERGE Record Counter application...